Preclinical
Imugene Limited, a clinical stage immuno-oncology company, announced new clinical data from the Phase Ib study of its HER-Vaxx cancer vaccine showing cancer fighting antibody and clinical response rates continue to be positive in the patients receiving the optimal biological dose of vaccine.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
According to a University College London (UCL) report, British researchers are being shut out of major European research partnerships because of concerns over a no-deal Brexit.
Orion Biotechnology Canada Ltd. announced the publication of preclinical data evaluating the efficacy of OB-002 in a murine model of multiple sclerosis in Science Translation Medicine
Exicure, Inc., a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid constructs, announced data from a preclinical study evaluating the biodistribution of SNAs in the non-human primate central nervous system.
Researchers discovered a pathway that helps regulate inflammation and also prevents the buildup of toxic proteins related to Alzheimer’s.
Using human induced pluripotent stem cells (iPSCs), researchers with Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California, were able to grow natural-looking hair that grows through the skin.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Researchers at Oregon State University recently improved on a technique using magnetic nanoclusters. Their research was published in May in the journal ACS Nano.
Ongoing pivotal Phase II clinical trial of ADCT-402 in patients with relapsed or refractory diffuse large B-cell lymphoma anticipated to complete enrollment in third quarter of 2019
PRESS RELEASES